| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210723 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 43 Pages |
Abstract
Consolidation chemotherapy with 2 cycles of capecitabine and oxaliplatin demonstrated a marginal improvement in the downstaging rate. However, a phase 3 trial of this strategy is discouraged because of the high dropout rate and safety issues.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sun Young MD, PhD, Jungnam PhD, Tae Won MD, PhD, Yong Sang MD, PhD, Jeong Eun MD, PhD, In Gyu MD, PhD, Beom Gyu MD, PhD, Keun-Wook MD, PhD, Ji-Won MD, Ho-Suk MD, PhD, Joong Bae MD, PhD, Dae Young MD, PhD, Dae Yong MD, PhD, Jae Hwan MD, PhD, Ji Yeon MD,